Form 4: USCB CEO Granted 27,632 Restricted Shares
Insider Transaction Disclosure
USCB Financial Holdings' President and CEO, Luis de la Aguilera, was granted 27,632 restricted shares of Class A Voting Common Stock.
Summary
- Luis de la Aguilera, President and CEO of USCB Financial Holdings, Inc. (USCB), was granted 27,632 shares of Class A Voting Common Stock.
- The newly granted restricted shares vest at a rate of one-third per year, commencing on January 27, 2027.
- Following this transaction, Mr. de la Aguilera beneficially owns 245,893 shares of Class A Voting Common Stock.
- The beneficial ownership includes previously granted restricted stock with various vesting schedules: 17,082 shares from a 25,653-share grant (vesting commenced 01/21/2026), 4,045 shares from a 12,136-share grant (vesting commenced 01/22/2025), 7,892 shares from a 23,678-share grant (vesting commenced 03/08/2024), and 41,666 shares from a 125,000-share grant (vesting commenced 12/31/2024).
- Mr. de la Aguilera also holds stock options: 40,000 options with an exercise price of $11.35 (vesting commenced 09/23/2020, expires 09/23/2029), 160,000 options with an exercise price of $12.05 (vesting commenced 09/27/2022, expires 09/27/2031), and 10,000 options with an exercise price of $7.50 (vesting commenced 04/01/2017, expires 04/01/2026).
Sentiment
Score: 6
Explanation: The grant of restricted stock to the CEO is generally viewed as a positive development, as it aligns management's interests with those of shareholders and serves as a retention mechanism. It does not, however, provide direct insight into operational or financial performance.
Positives
- The grant of restricted stock to the President and CEO aligns management's long-term interests with those of shareholders, promoting executive retention and performance incentives.
- The transaction represents ongoing compensation for a key executive, indicating continued commitment to the company.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is a disclosure of an insider transaction.
Industry Context
This Form 4 filing is a routine disclosure of an insider equity transaction, common across all industries for publicly traded companies. It reflects standard executive compensation practices involving equity grants to align management incentives with shareholder value creation.
Related Party Transactions
- Grant of 27,632 shares of restricted stock to Luis de la Aguilera, President and CEO of USCB Financial Holdings, Inc.
Stakeholder Impact
- Shareholders: The grant of restricted stock to the CEO can be seen as a positive for shareholders as it aligns the executive's financial interests with the company's long-term performance, potentially encouraging decisions that enhance shareholder value.
- Employees: This transaction primarily impacts the executive, but executive compensation practices can influence overall employee morale and perception of fairness within the company.
Next Steps
- The newly granted 27,632 restricted shares will commence vesting at a rate of one-third per year starting on January 27, 2027.
Key Dates
| Date | Description |
|---|---|
| 04/01/2017 | Commencement of vesting for 10,000 stock options at 25% per year. |
| 09/23/2020 | Commencement of vesting for 40,000 stock options at one-third per year. |
| 09/27/2022 | Commencement of vesting for 160,000 stock options at one-third per year. |
| 03/08/2024 | Commencement of vesting for 23,678 shares of restricted stock at one-third per year. |
| 12/31/2024 | Commencement of vesting for 125,000 shares of restricted stock at one-third per year. |
| 01/22/2025 | Commencement of vesting for 12,136 shares of restricted stock at one-third per year. |
| 01/21/2026 | Commencement of vesting for 25,653 shares of restricted stock at one-third per year. |
| 01/27/2026 | Date of the reported transaction: grant of 27,632 shares of restricted stock. |
| 01/28/2026 | Signature date of the Form 4 filing. |
| 04/01/2026 | Expiration date for 10,000 stock options with an exercise price of $7.50. |
| 01/27/2027 | Commencement of vesting for the newly granted 27,632 shares of restricted stock at one-third per year. |
| 09/23/2029 | Expiration date for 40,000 stock options with an exercise price of $11.35. |
| 09/27/2031 | Expiration date for 160,000 stock options with an exercise price of $12.05. |
Keywords
USCB, Form 4, Insider Transaction, Restricted Stock, Stock Options, Executive Compensation, Equity Grant, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.